Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Bevacizumab and type 1 idiopat...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Bevacizumab and type 1 idiopathic macular telangiectasia
Bibliographic Details
Main Authors:
Koay, C.L.
,
Chew, F.L.M.
,
Visvaraja, S.
Format:
Article
Published:
2011
Subjects:
R Medicine
Holdings
Description
Similar Items
Staff View
Similar Items
Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
by: Tuğba Aydoğan, et al.
Published: (2016-12-01)
Topical piperacillin/tazobactam for recalcitrant pseudomonas aeruginosa keratitiS
by: Chew, F.L.M., et al.
Published: (2010)
Management of Idiopathic Macular Telangiectasia Type 2
by: Alireza Khodabande, et al.
Published: (2019-02-01)
Type 1 Idiopathic Macular Telangiectasia Associated with Type 3 Neovascularization
by: Julien Tilleul, et al.
Published: (2014-11-01)
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
by: Rishi Pukhraj, et al.
Published: (2009-01-01)